LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

LLY

1,072.27

+1.4%↑

JNJ

206

-1.09%↓

ABBV

227.14

+1.9%↑

UNH

327.43

-0.31%↓

AZN

91.35

+0.79%↑

Search

Premier Inc

Fermé

SecteurSoins de santé

28.25

Résumé

Variation du prix de l'action

24h

Actuel

Min

28.25

Max

28.25

Chiffres clés

By Trading Economics

Revenu

-993K

18M

Ventes

-23M

240M

P/E

Moyenne du Secteur

166.235

76.798

Rendement du dividende

2.97

Marge bénéficiaire

7.324

Employés

2,700

EBITDA

-7.9M

53M

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

-0.04% downside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

2.97%

2.37%

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

5.8M

2.3B

Ouverture précédente

28.25

Clôture précédente

28.25

Sentiment de l'Actualité

By Acuity

50%

50%

167 / 374 Classement par Healthcare

Score Technique

By Trading Central

Confiance

Weak Bullish Evidence

Premier Inc Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

18 déc. 2025, 23:54 UTC

Actions en Tendance

Stocks to Watch: Nike, Cassava Sciences, KB Home

18 déc. 2025, 23:51 UTC

Résultats

Nike Sales Tick Up in 2Q; China Weakness Persists -- Update

18 déc. 2025, 23:39 UTC

Principaux Mouvements du Marché

Cassava Sciences Shares Fall After FDA Places Hold on Epilepsy Drug Trial

18 déc. 2025, 22:57 UTC

Acquisitions, Fusions, Rachats

TikTok Signs Agreement for Sale of U.S. Unit, Axios Reports, Citing a Memo

18 déc. 2025, 21:40 UTC

Résultats

Nike Sales Tick Up, But China Weakness Persists

18 déc. 2025, 23:45 UTC

Market Talk

Gold Steady, Supported by Fed Rate-Cut Prospects -- Market Talk

18 déc. 2025, 23:37 UTC

Market Talk
Résultats

Nike 2Q Results Fail to Convince Investors of Recovery -- Market Talk

18 déc. 2025, 23:36 UTC

Market Talk

Nikkei May Rise, Tracking Wall Street's Rally -- Market Talk

18 déc. 2025, 23:03 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Impact on Consolidated Results for FY Ending March 2026 Likely to be Immaterial

18 déc. 2025, 23:02 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: To Acquire 4,448 Common Shares, 13,771 Preferred Shares of Co.

18 déc. 2025, 23:00 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Investment to Strengthen Recovery Network in U.S.

18 déc. 2025, 22:59 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Investment to Contribute to Expanding Collection Volume of Secondary Raw Material

18 déc. 2025, 22:58 UTC

Acquisitions, Fusions, Rachats

SpaceX Could Go Public by Merging With EchoStar. It Isn't a Crazy Idea. -- Barrons.com

18 déc. 2025, 22:57 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: Elemental USA E-Waste Operates E-Waste Recycling Business in U.S.

18 déc. 2025, 22:56 UTC

Acquisitions, Fusions, Rachats

Mitsubishi Materials: To Acquire Portion of Shares of Elemental USA E-Waste & ITAD

18 déc. 2025, 22:55 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:59 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:50 UTC

Market Talk
Résultats

Tech, Media & Telecom Roundup: Market Talk

18 déc. 2025, 21:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

18 déc. 2025, 21:35 UTC

Résultats

FedEx's Earnings Were Strong. Cost Cuts and Shipment Volume Helped. -- Barrons.com

18 déc. 2025, 21:31 UTC

Résultats

Nike Earnings Top Expectations. Why the Stock Is Down. -- Barrons.com

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Europe, Middle East & Africa Rev $3.39B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Greater China Rev Down 17% >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q EPS 53c >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Apparel Rev $3.91B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Equipment Rev $550M >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q N Amer Rev $5.63B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Footwear Rev $7.66B >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Asia Pacific & Latin America Rev Down 4% >NKE

18 déc. 2025, 21:15 UTC

Résultats

Nike 2Q Greater China Rev $1.42B >NKE

Comparaison

Variation de prix

Premier Inc prévision

Objectif de Prix

By TipRanks

-0.04% baisse

Prévisions sur 12 Mois

Moyen 28.25 USD  -0.04%

Haut 28.25 USD

Bas 28.25 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

5 ratings

0

Achat

5

Maintien

0

Vente

Score Technique

By Trading Central

20.38 / N/ASupport & Résistance

Court Terme

Weak Bullish Evidence

Moyen Terme

Weak Bearish Evidence

Long Terme

Strong Bullish Evidence

Sentiment

By Acuity

167 / 374Classement par Soins de santé

Sentiment de l'Actualité

Neutral

Volatilité

Inférieur à la moyenne

Changement du Volume d'Actualités (RCV)

Moyen

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Premier Inc

Premier, Inc., together with its subsidiaries, operates as a healthcare improvement company in the United States. It operates in two segments, Supply Chain Services and Performance Services. The Supply Chain Services segment offers its members with an access to a range of products and services, including medical and surgical products, pharmaceuticals, laboratory supplies, capital equipment, information technology, facilities and construction, and food and nutritional products, as well as purchased services, such as clinical engineering and workforce solutions. This segment also provides the ASCENDrive programs for members to receive group purchasing programs, tiers, and prices; SURPASS Performance Group services for coordinate purchasing decisions, review utilization and achieve and maintain standardization across member's facilities; SaaS informatics products for the purchase additional elements; supply chain co-management services; purchased services contracts; direct sourcing solutions; and supply chain resiliency programs. The Performance Services segment provides technology and services platform with offerings that help optimize performance in three main areas, including clinical intelligence, margin improvement, and value-based care under the PINC AI brand; third party administrator services and management of health benefit programs under the Contigo Health brand; and digital invoicing and payables services that offers financial support services to healthcare product suppliers and service providers under the Remitra brand. The company was incorporated in 2013 and is headquartered in Charlotte, North Carolina.
help-icon Live chat